Orbillion Bio specializes in producing premium cultivated beef, aiming to provide a sustainable alternative to traditional meat sources in the global ground beef market, which is valued at $211 billion. The company leverages its advanced cell culture platform, Orbiscale, which is designed to achieve high yields and significantly reduce capital expenditure (CAPEX) by 40%. This innovative approach positions Orbillion to reach price parity with conventional beef, allowing them to cater to both business-to-business (B2B) and business-to-business-to-consumer (B2B2C) markets across the US, Asia, and Europe.

The expertise of Orbillion's co-founders, who collectively possess over 35 years of experience in various fields including product development, food technology, biotechnology, biopharma, and sustainability, underpins the company's unique position in the cultivated meat industry. By focusing on scalable and sustainable production methods, Orbillion aims to transform the meat industry while addressing environmental concerns associated with traditional livestock farming. Their commitment to innovation and sustainability reflects a broader narrative of human ingenuity harmonizing with nature's resources.

United States

Orbillion is a B2B cultivated meat technology company that brings commercially-viable meat to the ever-growing $211B global ground beef market. Orbillion has developed a game-changing algorithm for the scale-up of cultivated meat that makes commercializing low-cost cultivated beef possible. The Orbillion founders bring more than 35 years of combined experience in biopharma bioprocessing, optimizing the very systems required to commercialize cultivated meat. Orbillion is backed by The Venture Collective, Y Combinator, At One Ventures, Venture Souq, and Metaplanet. Learn more and partner with us at www.orbillion.com.

Orbillion Bio

Company Details